Interleukin-1 receptor antagonist reduces mortality from endotoxin shock (original) (raw)

Nature volume 348, pages 550–552 (1990)Cite this article

Abstract

ABOUT five out of 1,000 patients admitted to hospital develop bacterial sepsis leading to shock1, the mortality rate for which is high despite antibiotic therapy2. The infection results in hypotension and poor tissue perfusion, and eventually leads to the failure of several organ systems. Bacterial endotoxin is thought to be the direct cause of shock in Gram-negative sepsis, because it can cause shock in animals3, and antibodies against endotoxin prevent Gram-negative shock in animals4 and in humans5–7. But, the symptoms of septic shock are the result of the actions of host cytokines induced by the endotoxin. The cytokiue interleukin-1 has been implicated as an important mediator of septic shock because it can induce tachycardia and hypotension and act synergistically with tumour necrosis factor to cause tissue damage8 and death9. We now report that a specific interleukin-1 receptor antagonist reduces the lethality of endotoxin-induced shock in rabbits, indicating that interleukin-1 does indeed play an important part in endotoxin shock.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Lode, H. Arzneimitteltherapie 1, 82–89 (1983).
    Google Scholar
  2. Kreger, B. E., Crave, D. E. & McCabe, W. R.,Am. J. Med. 68, 343–355 (1980).
    Article Google Scholar
  3. Guenter, C. A., Florcica, V. & Hinshaw, B. J. J. appl. Physiol. 26, 780–786 (1969).
    Article CAS Google Scholar
  4. Ziegler, E. J., Douglas, H., Sherman, J. E., Davis, C. E. & Braude, A. I. J. Immun. 111, 433–438 (1973).
    CAS PubMed Google Scholar
  5. Ziegler, E. J. et al. New Engl. J. Med. 307, 1255–1230 (1982).
    Article Google Scholar
  6. Ziegler, E., Sprung, C., Straube, R. & Sadoff, J. Clin. Res. 38, 304A (1990).
    Google Scholar
  7. Gorelick, K. J., Schein, R. M. H., Maclntyre, N. R., Emmanuel, G. & Bernard, G. R. Crit. Care Med. 18, S253 (1990).
    Article Google Scholar
  8. Okusawa, S., Gelfand, J. A., Ikejima, T., Connolly, R. J. & Dinarello, C. A. J. clin. Invest. 81, 1162–1172 (1988).
    Article CAS Google Scholar
  9. Everaerdt, B., Brouckaert, P., Shaw, A. & Fiers, W. Biochem. biophys. Res. Commun., 163, 378–385 (1989).
    Article CAS Google Scholar
  10. Hannum, C. H. et al. Nature 343, 336–340 (1990).
    Article ADS CAS Google Scholar
  11. Eisenberg, S. P. et al. Nature 343, 341–346 (1990).
    Article ADS CAS Google Scholar
  12. Arend, W. P., Welgus, H. G., Thompson, R. C. & Eisenberg, S. P. J. clin. Invest. 85, 1694–1697 (1990).
    Article CAS Google Scholar
  13. Mancini, G., Carbonnara, A. O. & Heremans, J. Immunochemistry 2, 235–254 (1965).
    Article CAS Google Scholar
  14. Michie, H. R. et al. New Engl. J. Med. 318, 1481–1486 (1988).
    Article CAS Google Scholar
  15. Tracey, K. J. et al. Science 234, 470–474 (1986).
    Article ADS CAS Google Scholar
  16. Tracey, K. J. et al. Nature 330, 662–664 (1987).
    Article ADS CAS Google Scholar
  17. Beutler, B., Milsark, I. & Cerami, A. Science 229, 869–871 (1985).
    Article ADS CAS Google Scholar

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Pathophysiology, University of Lund,Malmo General Hospital, S21401, Malmo, Sweden
    Kjell Ohlsson, Peter Björk & Magnus Bergenfeldt
  2. Synergen, Inc., 1885 33rd Street, Boulder, Colorado, 80301, USA
    Robert Hageman & Robert C. Thompson

Authors

  1. Kjell Ohlsson
  2. Peter Björk
  3. Magnus Bergenfeldt
  4. Robert Hageman
  5. Robert C. Thompson

Rights and permissions

About this article

Cite this article

Ohlsson, K., Björk, P., Bergenfeldt, M. et al. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock.Nature 348, 550–552 (1990). https://doi.org/10.1038/348550a0

Download citation

This article is cited by